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Abstract 
 Chlamydia trachomatis is a Gram negative, obligate intracellular bacterium responsible 
for the most common reportable bacterial sexually transmitted infection in the United States and 
the leading infectious cause of preventable blindness worldwide. This pathogen undergoes a 
unique biphasic developmental cycle where it alternates between its infectious form, termed the 
elementary body (EB), and its replicative form, termed the reticulate body (RB). We hypothesize 
that reversible phosphorylation regulates the differentiation of the bacterium between these two 
forms. In order to study phosphorylation in Chlamydia, it is necessary to examine the role of 
individual kinases and phosphatases in the organism. My project focuses on using the 
Bacteriomatch II Two-Hybrid System to search for binding partners for the chlamydial 
phosphatase protein Cpp1. In particular, my project will test for interactions with a cysteine 
desulfurase and the elongation factor EF-Tu. Binding will be determined by streptomycin 
resistance and histidine production using the Bacteriomatch system. Successful identification of 
binding partners for Cpp1 could further our understanding of essential regulatory mechanisms in 
C. trachomatis and could lead to the identification of potential drug targets in the future. 
 
 
 
 
 
 
Introduction 
 Chlamydia are obligate intracellular bacterial pathogens responsible for numerous human 
diseases, including the most common reportable bacterial sexually transmitted infection in the 
United States (Vasilevsky et al., 2014). In particular, Chlamydia trachomatis in humans is 
divided into three biovars: serovars A-C, serovars D-K, and serovars L1-L3. Serovars A-C cause 
trachoma (Vasilevsky et al., 2014), the leading infectious cause of preventable blindness 
worldwide (Centers for Disease Control and Prevention, 2009). Serovars D-K cause urethritis, 
pelvic inflammatory disease, and neonatal conjunctivitis. Lastly, serovars L1-L3 cause 
lymphogranuloma venereum (Vasilevsky et al., 2014). C. trachomatis undergoes a unique 
biphasic developmental cycle where it alternates between its infectious form, termed the 
elementary body (EB), and the replicative form, termed the reticulate body (RB) (Claywell et al., 
2016). Upon infection of a host, the elementary body utilizes a type III secretion system to 
facilitate its entry into an epithelial host cell (Moore and Ouellette, 2014). Once inside the host 
cell, the bacteria differentiate from EBs into RBs and replicate inside a host-derived inclusion 
until RBs asynchronously differentiate back into EBs (Claywell et al., 2016). However, little is 
known about how the bacterium regulates the differentiation between its two forms. 
 Reversible phosphorylation on Ser/Thr/Tyr residues has been gaining recognition as an 
important global regulatory mechanism in many pathogens (Mijakovic, Macek, 2012). 
Phosphoproteomic analysis of C. caviae, a close relative of C. trachomatis, showed a threefold 
increase in phosphoproteins in the EB form when compared to the RB form, and only three 
phosphoproteins were shared (Fisher et al., 2015). 80% of the genes in C. caviae have homologs 
in C. trachomatis, and 41 of the 42 phosphoproteins identified have homologues in all 
chlamydial species. Additionally, phosphoproteins in the EB form were found to have functions 
in central and secondary metabolism, amino acid metabolism, and virulence, whereas 
phosphoproteins in the RB form functioned in protein synthesis and folding (Fisher et al., 2015). 
This supports the hypothesis that the differentiation of C. trachomatis between its two forms is 
regulated by reversible phosphorylation.  
 Reversible phosphorylation typically involves the addition and removal of phosphate 
groups by kinases and phosphatases, respectively. C. trachomatis has two characterized Hank’s 
type kinases, Pkn1 and PknD, which have been shown to autophosphorylate Ser/Thr residues and 
to interact with each other (Verma, Maurelli, 2003). It also encodes a putative pseudokinase 
Pkn5, which lacks conserved catalytic residues, and a putative arginine kinase, McsB (Verma, 
Maurelli, 2003). The bacterium also produces three phosphatases: Cpp1, RsbU, and CT_589 
(Hua et al., 2006). The latter two phosphatases are assigned to the partner-switching mechanism 
in C. trachomatis (Hua et al., 2006), which is hypothesized to regulate sigma 66 availability 
(Thompson et al., 2015). This makes Cpp1 a likely candidate as the cognate phosphatase of Pkn1 
and PknD and implies that it might have a significant role in regulating the EB to RB transition. 
For an overview of phosphorylation in Chlamydia, see Claywell et al., 2016.  
 Cpp1 is a characterized protein phosphatase type 2C that has been shown to 
dephosphorylate Ser/Thr/Tyr phosphopeptides, suggesting that it may be able to dephosphorylate 
multiple substrates in C. trachomatis (Claywell, Fisher, 2016). However, the substrates of Cpp1 
in vivo have not been identified, and it is necessary to investigate this topic in order to understand 
the role of the enzyme. My research will use a bacterial two-hybrid system to identify binding 
partners of Cpp1. However, before using a two-hybrid system, it is essential to first determine if 
the system-required protein tags interfere with the activity of the enzyme. The first portion of my 
research used pNPP hydrolysis assays to look for increased phosphatase activity in strains 
containing Cpp1 compared to empty vector strains. Increased phosphatase activity would 
indicate that the protein tags did not interfere with enzyme activity and that the system would be 
a suitable system to use in the search for binding partners. The Bacterial Adenylate Cyclase-
based Two-Hybrid (BACTH) system by Euromedex and the Bacteriomatch II Two-Hybrid 
system by Stratagene were both tested, and the latter was identified as a suitable two-hybrid 
system. After this experiment, I will move forward with the Bacteriomatch system to identify 
binding partners of Cpp1. If successful, this would help further our understanding of the role of 
reversible phosphorylation in chlamydial regulation and could lead to the identification of drug 
targets for use in treating chlamydial infections. 
 The BACTH system utilizes the unique ability of an adenylate cyclase protein from 
Bordetella pertussis to become active if two fragments of its catalytic domain are brought 
together. These two fragments, T18 and T25, can be fused to an enzyme and another protein and 
will produce cAMP if the two proteins interact. Once enough cAMP is produced, the cAMP will 
bind to CAP proteins and activate transcription of the lac operon downstream from the cAMP-
CAP promoter (Figure 1). The reporter gene is lacZ, which encodes for β-galactosidase. β-
galactosidase assays can be used to detect increased production of β-galactosidase in Escherichia 
coli strains containing the constructs. Growth on X-gal media can also be used to detect β-
galactosidase production by blue-white screening (Karimova et al., 1998). 
 In the Bacteriomatch system, the enzyme is fused to the λCI repressor, and the potential 
binding partner is fused to the α subunit of the RNA polymerase. When the λCI operator site is 
moved upstream of a promoter, interaction between the enzyme and its binding partner allows 
for the recruitment of the RNAP to the promoter, and transcription of reporter genes occurs. In 
this system, histidine biosynthesis genes and streptomycin resistance genes are the reporter genes 
(Figure 2). After cotransformation of plasmid constructs containing the enzyme and the potential 
binding partner into a strain auxotrophic for histidine, interaction between the two proteins 
would result in the ability of the bacterium to grow on media containing streptomycin and 
lacking histidine supplementation (Agilent Technologies, 2008). My research involved making 
plasmid constructs for each system containing Cpp1, putting these plasmids in E. coli, and 
comparing phosphatase activity of these strains with strains containing only empty vector 
plasmids. 
 
 
Figure 1. Principle of the BACTH System. 
 
 
Figure 2. Principle of the Bacteriomatch II Two-Hybrid System. 
 
 
Procedure 
 In order to test for Cpp1 activity when fused to tags required by the BACTH system, we 
inserted cpp1 into the system-supplied plasmids. We were able to obtain plasmids that would 
produce Cpp1 fused to both fragments at the N-terminus or the C-terminus (Figure 3). Plasmids 
were transformed into BTH101 and DHM1 strains of E. coli, and cultures were grown to mid-
logarithmic phase at 37ᴼC before induction with varying levels of IPTG. OD600 readings were 
taken at least every half hour until values were between 0.7 and 0.9. Protein production was 
initially induced with 0.5 mM IPTG at 18ᴼC for 24 hours. IPTG concentrations of 0 mM and 1 
mM were also tested with the DHM1 strains After induction, OD600 values for each individual 
culture were taken, and cultures were pelleted before storage at -20ᴼC.  
 In order to test for Cpp1 activity when fused to tags required by the Bacteriomatch 
system, cpp1 was inserted into the system-supplied plasmid. This construct and an empty vector 
plasmid were transformed separately into E. coli (Figure 4), and cultures were again grown to 
mid-logarithmic phase at 37ᴼC before induction. Protein production was initially induced with 
30µM of IPTG at 18ᴼC for 16-20 hours and 37ᴼC for 4-5 hours. Induction was also performed at 
room temperature for 16-20 hours and 30ᴼC for 5-6 hours. OD600 readings for each culture were 
taken before pelleting and storage at -20ᴼC. Cells were lysed by sonication, and pNPP hydrolysis 
assays were performed on crude whole-cell lysates using MnCl2, pH 8 assay buffer, and p-
nitrophenyl phosphate (pNPP) (Claywell, Fisher, 2016). Purified Cpp1 protein was used as a 
positive control, and assay buffer alone along with empty vector strains were used as negative 
controls. Absorbance values were taken using a plate reader, and these values were divided by 
corresponding OD600 readings to correct for growth differences between strains.  
 After analysis of phosphatase activity using each system, the Bacteriomatch system was 
identified as a suitable bacterial two-hybrid system. cpp1 along with the genes for potential 
binding partners tufA, which encodes for elongation factor EF-TU, and CTL0510, which is a 
cysteine desulfurase found in an operon with cpp1 in the chlamydial genome, were amplified by 
PCR from C. trachomatis L2 434 genomic DNA. After amplification, PCR products were 
inserted into pJET1.2/blunt cloning vector. These plasmids were digested using restriction 
enzymes, and digested inserts were purified using a gel clean-up kit. pBT bait plasmid and pTRG 
target plasmids were also digested before inserts were ligated into the plasmids at the MCS 
(Figure 5). Plasmids were transformed into the XL1 blue MRF’ kan strain of E. coli, and 
colonies containing the inserts were identified using colony PCR. Sequence analysis was done to 
confirm the presence of the inserts in the plasmids before continuing. pBT plasmid containing 
cpp1 and pTRG plasmid containing either tufA or CTL0510 were cotransformed into the reporter 
strain. This is where we currently are in the project, but we will be plating cotransformants on 
media lacking histidine and containing streptomycin in the future to test for interactions between 
our potential binding partners and Cpp1. We are hoping that either TufA or CTL0510 interacts 
with Cpp1 and allows the cotransformants to grow on the selective media.  
 
Figure 3. Tags in strains used for testing the BACTH system. 
 
 Figure 4. Tags in strains used for testing the Bacteriomatch II Two-Hybrid System. 
 
              pBT 511                          pTRG tufA/CTL0510 
 
Figure 5. Vector maps of constructs used to test for interactions between Cpp1 and 
potential binding partners.  
 
Results 
 For the BACTH system, we saw no increases in phosphatase activity in strains containing 
Cpp1 when compared to strains not containing Cpp1 even after varying induction temperatures, 
inducer concentrations, and the bacterial strain (Figure 6, Figure 7). There was no significant 
difference or pattern when comparing A405 values for strains labelled with “511” in the legends 
of the figures. It is important to note that the positive control typically had values too high for the 
plate reader to read within the first few minutes of the assay. Therefore, the values used in the 
figures only represent the first couple of readings taken, and these values appear much lesser 
than the others because the other values were adjusted for culture absorbance. The values for the 
positive control were not adjusted for culture absorbance since purified protein was used in these 
wells. Although it is not represented clearly in the graphs, the positive control values were much 
higher than the values for any other wells in the experiment.  
 In contrast, when testing the Bacteriomatch system, we saw significant increases in 
phosphatase activity in strains containing Cpp1 (labelled with “511” in the legends) when 
compared to strains not containing Cpp1 (Figure 8, Figure 9). However, this increase in activity 
seems to be more significant when protein production is induced at lower temperatures for longer 
times. At 18ᴼC, we saw the largest increase in phosphatase activity in the DF204 strain, but there 
was little difference at 37ᴼC (Figure 8). Because it would take a very long time to grow cultures 
at 18ᴼC when testing for interactions, we wanted to find a warmer temperature where functional 
Cpp1 production was still significant. We ran pNPP hydrolysis assays at room temperature and 
30ᴼC, and we saw the same pattern of increased phosphatase activity in Cpp1-containing strains. 
Induction at room temperature seemed to produce enough Cpp1 to allow for significant increases 
in phosphatase activity, and growth at room temperature would take a more reasonable amount 
of time when using this system to search for binding partners.  
 
 Figure 6. Absorbance values for pNPP hydrolysis assays after induction with 0.5 mM IPTG 
at 18ºC for 24 hours. Strains labelled B were BTH101 E. coli strains, and strains labelled D 
were DHM1 E. coli strains. 
 
 
 Figure 7. Absorbance values for pNPP hydrolysis assays after induction at 18ºC for 24 
hours. The DHM1 strains labelled with IPTG were induced with 1 mM IPTG. The other 
DHM1 strains were not supplemented with IPTG. 
 
 
 Figure 8. Absorbance values for pNPP hydrolysis assays after induction at 18ºC for 16-20 
hours or at 37ºC for 4-5 hours as indicated. IPTG concentration for induction was 30 μM 
for all strains. 
 
 Figure 9. Absorbance values for pNPP hydrolysis assay after induction with 30 µM IPTG 
for 16-20 hours at RT or 5-6 hours at 30ᴼC. 
 
Discussion 
 After looking for increases in phosphatase activity in strains containing Cpp1 when 
compared to empty vector strains, we concluded that the Bacteriomatch system is a suitable 
bacterial two-hybrid system to use to test for binding partners of Cpp1, whereas the BACTH 
system is not. Even after changing induction conditions and the strains used, we saw no 
significant differences or patterns in phosphatase activity between the strains used to test the 
BACTH system (Figure 6, Figure 7). The system-required protein tags likely interfered with 
folding or catalysis of Cpp1. However, when Cpp1 was fused to the CI repressor as in the 
Bacteriomatch system, we saw increases in phosphatase activity in the DF204 strain when 
compared to the empty vector strain (Figure 8, Figure 9). We also saw that the difference in 
phosphatase activity was larger when induction was performed at lower temperatures. This may 
have been due to the enzyme having an optimal temperature for folding or due to the buildup of 
toxic products in the cells. Because growth at 18ᴼC would take a long time, we will likely grow 
the bacteria at room temperature when using the system in the future. This slightly warmer 
temperature still produced a significant difference in phosphatase activity. 
In the future, we will be using the Bacteriomatch system to test the elongation factor 
TufA and the cysteine desulfurase CTL0510 for interactions with Cpp1. CTL0510 is of interest 
because it is found in an operon with cpp1 in the genome of C. trachomatis. In addition, TufA 
was identified as a phosphoprotein in the phosphoproteomic analysis of C. caviae discussed 
earlier (Fisher et al., 2015). This may indicate that C. trachomatis regulates the differentiation 
between its two developmental forms with a mechanism similar to that of Bacillus subtilis, 
which uses phosphorylation of TufA to regulate sporulation of the bacterium (Pereira et al., 
2015). We have already been successful in creating constructs with cpp1 inserted into the pBT 
plasmid and tufA and CTL0510 inserted into pTRG plasmids. We will be cotransforming these 
plasmids into the Bacteriomatch reporter strain and plating on media containing streptomycin 
and lacking histidine. Now that we have identified a suitable system, we are hoping that we will 
be able to identify at least one binding partner for Cpp1. Identification of a binding partner for 
this phosphatase could lead to identification of drug targets and could help elucidate the role of 
reversible phosphorylation in developmental regulation of C. trachomatis. 
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